Antigen rapid test, from the pharmaceutical company BioJam, allows to detect if a person has COVID-19, in 15 minutes, from the first 24 hours of contagion. The pharmaceutical company has already notified INFARMED to put the test on the market.
For the distribution of the NADAL COVID-19 Ag rapid antigen tests, the pharmaceutical company BioJam indicated that it has already notified INFARMED. The test allows detection, from the first 24 hours of infection, of a protein of the coronavirus that causes COVID-19, thus determining the infection.
These rapid tests allow filling a gap in the quick diagnosis in the early stage of infection, as they have a detection window similar to current PCR tests.
The tests do not require instrumentation, and the results are obtained in just 15 minutes, significantly reducing false positives caused by contamination from other tests.
The NADAL rapid antigen tests, manufactured in Germany, provide essential information at the time of the infection period when there is a higher risk of disease transmission. This rapid test "constitutes a reliable and affordable tool for detecting infection outbreaks on a large scale, thus reducing the spread of the disease."
This diagnostic tool is based on a lateral flow system, which does not require instrumentation, meaning the test is performed with a simple device that detects the presence of a substance in a liquid sample without the need for specialized and expensive equipment.
A quick and economical solution for companies
NADAL antigen tests are fast, cheap, and accessible, allowing for COVID-19 testing on a large scale, quickly identifying infected individuals, and reducing the spread of the coronavirus, presenting several advantages for workplaces and companies.
Carlos Monteiro, CEO and Founder of BioJam Holding Group, clarified: "Rapid antigen tests are the fastest and most economical option for companies wishing to test their employees, thus combating the economic and social impact associated with work absenteeism imposed by quarantine periods. In this way, companies can maintain their normal activity while ensuring the safety of all employees."
Considering the technique of collecting samples by swab, BioJam indicated that it offers the possibility of performing NADAL antigen tests at the Clínica Pilares da Saúde in Lisbon and at the Oporto Pain Free Clinic in Porto, for those who do not have a healthcare professional within the company.
BioJam can also provide healthcare professionals to conduct tests within the companies themselves, ensuring a rapid response in controlling possible cases of COVID-19 infection.
News published on TV Europa
https://www.tveuropa.pt/noticias/teste-da-biojam-permite-detetar-covid-19-em-15-minutos/